<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35182479</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4164</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>03</Day></PubDate></JournalIssue><Title>Molecular cell</Title><ISOAbbreviation>Mol Cell</ISOAbbreviation></Journal><ArticleTitle>Poly(ADP-ribose) drives condensation of FUS via a transient interaction.</ArticleTitle><Pagination><StartPage>969</StartPage><EndPage>985.e11</EndPage><MedlinePgn>969-985.e11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molcel.2022.01.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1097-2765(22)00061-2</ELocationID><Abstract><AbstractText>Poly(ADP-ribose) (PAR) is an RNA-like polymer that regulates an increasing number of biological processes. Dysregulation of PAR is implicated in neurodegenerative diseases characterized by abnormal protein aggregation, including amyotrophic lateral sclerosis (ALS). PAR forms condensates with FUS, an RNA-binding protein linked with ALS, through an unknown mechanism. Here, we demonstrate that a strikingly low concentration of PAR (1&#xa0;nM) is sufficient to trigger condensation of FUS near its physiological concentration (1&#xa0;&#x3bc;M), which is three orders of magnitude lower than the concentration at which RNA induces condensation (1&#xa0;&#x3bc;M). Unlike RNA, which associates with FUS stably, PAR interacts with FUS transiently, triggering FUS to oligomerize into condensates. Moreover, inhibition of a major PAR-synthesizing enzyme, PARP5a, diminishes FUS condensation in cells. Despite their structural similarity, PAR and RNA co-condense with FUS, driven by disparate modes of interaction with FUS. Thus, we uncover a mechanism by which PAR potently seeds FUS condensation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rhine</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Program in Cell, Molecular, Developmental Biology, and Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA; Department of Biology, Johns Hopkins University, Baltimore, MD 21218, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dasovich</LastName><ForeName>Morgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Chemistry-Biology Interface Program, Johns Hopkins University, Baltimore, MD 21218, USA; Department of Chemistry, Johns Hopkins University, Baltimore, MD 21218, USA; Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoniles</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badiee</LastName><ForeName>Mohsen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skanchy</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganser</LastName><ForeName>Laura R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Yingda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fare</LastName><ForeName>Charlotte M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorter</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Anthony K L</ForeName><Initials>AKL</Initials><AffiliationInfo><Affiliation>Chemistry-Biology Interface Program, Johns Hopkins University, Baltimore, MD 21218, USA; Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA; Department of Molecular Biology and Genetics, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA; McKusick-Nathans Department of Genetic Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA; Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA. Electronic address: anthony.leung@jhu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myong</LastName><ForeName>Sua</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Program in Cell, Molecular, Developmental Biology, and Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA; Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA; Physics Frontier Center (Center for the Physics of Living Cells), University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. Electronic address: smyong@jhu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 NS113439</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS090205</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 NS111870</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS113636</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM008275</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG071326</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007231</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM080189</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM104135</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA009110</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD025221</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cell</MedlineTA><NlmUniqueID>9802571</NlmUniqueID><ISSNLinking>1097-2765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>26656-46-2</RegistryNumber><NameOfSubstance UI="D011064">Poly Adenosine Diphosphate Ribose</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011064" MajorTopicYN="Y">Poly Adenosine Diphosphate Ribose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">LLPS</Keyword><Keyword MajorTopicYN="N">PARP5a</Keyword><Keyword MajorTopicYN="N">PARylation</Keyword><Keyword MajorTopicYN="N">RNA</Keyword><Keyword MajorTopicYN="N">condensation</Keyword><Keyword MajorTopicYN="N">length dependence</Keyword><Keyword MajorTopicYN="N">poly(ADP-ribose)</Keyword><Keyword MajorTopicYN="N">stress response</Keyword><Keyword MajorTopicYN="N">transient interaction</Keyword></KeywordList><CoiStatement>Declaration of interests J.S. is a consultant for Dewpoint Therapeutics, Maze Therapeutics, Vivid Sciences, Korro, and ADRx. S.M. is an advisory board member for the Molecular Cell. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>19</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35182479</ArticleId><ArticleId IdType="mid">NIHMS1777253</ArticleId><ArticleId IdType="pmc">PMC9330637</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2022.01.018</ArticleId><ArticleId IdType="pii">S1097-2765(22)00061-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abraham R, McPherson RL, Dasovich M, Badiee M, Leung AKL, and Griffin DE (2020). Both ADP-Ribosyl-Binding and Hydrolase Activities of the Alphavirus nsP3 Macrodomain Affect Neurovirulence in Mice. mBio 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7018654</ArticleId><ArticleId IdType="pubmed">32047134</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, Gladfelter A, and Mittag T. (2019). Considerations and Challenges in Studying Liquid-Liquid Phase Separation and Biomolecular Condensates. Cell 176, 419&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6445271</ArticleId><ArticleId IdType="pubmed">30682370</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmeyer M, Neelsen KJ, Teloni F, Pozdnyakova I, Pellegrino S, Grofte M, Rask MD, Streicher W, Jungmichel S, Nielsen ML, et al. (2015). Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose). Nat Commun 6, 8088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4560800</ArticleId><ArticleId IdType="pubmed">26286827</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando Y, Elkayam E, McPherson RL, Dasovich M, Cheng SJ, Voorneveld J, Filippov DV, Ong SE, Joshua-Tor L, and Leung AKL (2019). ELTA: Enzymatic Labeling of Terminal ADP-Ribose. Mol Cell 73, 845&#x2013;856 e845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6629254</ArticleId><ArticleId IdType="pubmed">30712989</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrabi SA, Kim NS, Yu SW, Wang H, Koh DW, Sasaki M, Klaus JA, Otsuka T, Zhang Z, Koehler RC, et al. (2006). Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci U S A 103, 18308&#x2013;18313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1838747</ArticleId><ArticleId IdType="pubmed">17116882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayyappan V, Wat R, Barber C, Vivelo CA, Gauch K, Visanpattanasin P, Cook G, Sazeides C, and Leung AKL (2021). ADPriboDB 2.0: an updated database of ADP-ribosylated proteins. Nucleic Acids Res 49, D261&#x2013;D265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778992</ArticleId><ArticleId IdType="pubmed">33137182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E, Boeynaems S, Kato M, Guo L, Caulfield TR, Steyaert J, Scheveneels W, Wilmans N, Haeck W, Hersmus N, et al. (2018). Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity. Cell Rep 24, 529&#x2013;537 e524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077250</ArticleId><ArticleId IdType="pubmed">30021151</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JM, Holehouse AS, and Pappu RV (2020). Physical Principles Underlying the Complex Biology of Intracellular Phase Transitions. Annu Rev Biophys 49, 107&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">32004090</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle JG, Lanson NA Jr., Smith RB, Casci I, Maltare A, Monaghan J, Nichols CD, Kryndushkin D, Shewmaker F, and Pandey UB (2013). RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum Mol Genet 22, 1193&#x2013;1205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3578413</ArticleId><ArticleId IdType="pubmed">23257289</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasovich M, Beckett MQ, Bailey S, Ong SE, Greenberg MM, and Leung AKL (2021). Identifying Poly(ADP-ribose)-Binding Proteins with Photoaffinity-Based Proteomics. J Am Chem Soc 143, 3037&#x2013;3042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8109396</ArticleId><ArticleId IdType="pubmed">33596067</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H, Gao K, and Jankovic J. (2014). The role of FUS gene variants in neurodegenerative diseases. Nat Rev Neurol 10, 337&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Dini Modigliani S, Morlando M, Errichelli L, Sabatelli M, and Bozzoni I. (2014). An ALS-associated mutation in the FUS 3&#x2019;-UTR disrupts a microRNA-FUS regulatory circuitry. Nat Commun 5, 4335.</Citation><ArticleIdList><ArticleId IdType="pubmed">25004804</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IR, Capell A, Schmid B, et al. (2010). ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29, 2841&#x2013;2857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y, Du A, Gu J, Duan G, Wang C, Gui X, Ma Z, Qian B, Deng X, Zhang K, et al. (2019). PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. Cell Res 29, 233&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6460439</ArticleId><ArticleId IdType="pubmed">30728452</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbaum-Garfinkle S. (2019). Matter over mind: Liquid phase separation and neurodegeneration. J Biol Chem 294, 7160&#x2013;7168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6509495</ArticleId><ArticleId IdType="pubmed">30914480</ArticleId></ArticleIdList></Reference><Reference><Citation>Evers B, Drost R, Schut E, de Bruin M, van der Burg E, Derksen PW, Holstege H, Liu X, van Drunen E, Beverloo HB, et al. (2008). Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin. Clin Cancer Res 14, 3916&#x2013;3925.</Citation><ArticleIdList><ArticleId IdType="pubmed">18559613</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahrer J, Kranaster R, Altmeyer M, Marx A, and Burkle A. (2007). Quantitative analysis of the binding affinity of poly(ADP-ribose) to specific binding proteins as a function of chain length. Nucleic Acids Res 35, e143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2175335</ArticleId><ArticleId IdType="pubmed">17991682</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahrer J, Popp O, Malanga M, Beneke S, Markovitz DM, Ferrando-May E, Burkle A, and Kappes F. (2010). High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length. Biochemistry 49, 7119&#x2013;7130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929705</ArticleId><ArticleId IdType="pubmed">20669926</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujioka Y, Alam JM, Noshiro D, Mouri K, Ando T, Okada Y, May AI, Knorr RL, Suzuki K, Ohsumi Y, et al. (2020). Phase separation organizes the site of autophagosome formation. Nature.</Citation><ArticleIdList><ArticleId IdType="pubmed">32025038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh SG, Becker K, Huang H, Dixon-Salazar T, Chai G, Salpietro V, Al-Gazali L, Waisfisz Q, Wang H, Vaux KK, et al. (2018). Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome. Am J Hum Genet 103, 826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6218605</ArticleId><ArticleId IdType="pubmed">30388405</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson BA, and Kraus WL (2012). New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 13, 411&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">22713970</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Kim HJ, Wang H, Monaghan J, Freyermuth F, Sung JC, O&#x2019;Donovan K, Fare CM, Diaz Z, Singh N, et al. (2018). Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains. Cell 173, 677&#x2013;692 e620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanai S, Kanai M, Ohashi S, Okamoto K, Yamada M, Takahashi H, and Miwa M. (2004). Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proc Natl Acad Sci U S A 101, 82&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC314142</ArticleId><ArticleId IdType="pubmed">14676324</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmon TS, Holehouse AS, Rosen MK, and Pappu RV (2017). Intrinsically disordered linkers determine the interplay between phase separation and gelation in multivalent proteins. Elife 6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5703641</ArticleId><ArticleId IdType="pubmed">29091028</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AF, and Shorter J. (2017). RNA-binding proteins with prion-like domains in health and disease. Biochem J 474, 1417&#x2013;1438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5639257</ArticleId><ArticleId IdType="pubmed">28389532</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatakeyama K, Nemoto Y, Ueda K, and Hayaishi O. (1986). Purification and characterization of poly(ADP-ribose) glycohydrolase. Different modes of action on large and small poly(ADP-ribose). J Biol Chem 261, 14902&#x2013;14911.</Citation><ArticleIdList><ArticleId IdType="pubmed">3771556</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, Hutten S, Bourgeois B, Spreitzer E, Niedner-Boblenz A, Schifferer M, Ruepp MD, Simons M, Niessing D, Madl T, et al. (2018). Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation. Cell 173, 706&#x2013;719 e713.</Citation><ArticleIdList><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner S, et al. (2009). Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pubmed">19759537</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman AA, Weber CA, and Julicher F. (2014). Liquid-liquid phase separation in biology. Annu Rev Cell Dev Biol 30, 39&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">25288112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S, Panicker N, Chen R, et al. (2018). Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson&#x2019;s disease. Science 362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431793</ArticleId><ArticleId IdType="pubmed">30385548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroschwald S, Maharana S, and Simon A. (2017). Hexanediol: a chemical probe to investigate the material properties of membrane-less compartments. Matters.</Citation></Reference><Reference><Citation>Kwiatkowski TJ Jr., Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung AK (2014). Poly(ADP-ribose): an organizer of cellular architecture. J Cell Biol 205, 613&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4050725</ArticleId><ArticleId IdType="pubmed">24914234</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung AK, Vyas S, Rood JE, Bhutkar A, Sharp PA, and Chang P. (2011). Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol Cell 42, 489&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898460</ArticleId><ArticleId IdType="pubmed">21596313</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung AKL (2020). Poly(ADP-ribose): A Dynamic Trigger for Biomolecular Condensate Formation. Trends Cell Biol 30, 370&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326565</ArticleId><ArticleId IdType="pubmed">32302549</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Banjade S, Cheng HC, Kim S, Chen B, Guo L, Llaguno M, Hollingsworth JV, King DS, Banani SF, et al. (2012). Phase transitions in the assembly of multivalent signalling proteins. Nature 483, 336&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3343696</ArticleId><ArticleId IdType="pubmed">22398450</ArticleId></ArticleIdList></Reference><Reference><Citation>Loughlin FE, Lukavsky PJ, Kazeeva T, Reber S, Hock EM, Colombo M, Von Schroetter C, Pauli P, Clery A, Muhlemann O, et al. (2019). The Solution Structure of FUS Bound to RNA Reveals a Bipartite Mode of RNA Recognition with Both Sequence and Shape Specificity. Mol Cell 73, 490&#x2013;504 e496.</Citation><ArticleIdList><ArticleId IdType="pubmed">30581145</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S, Wang J, Papadopoulos DK, Richter D, Pozniakovsky A, Poser I, Bickle M, Rizk S, Guillen-Boixet J, Franzmann TM, et al. (2018). RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science 360, 918&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin EW, Holehouse AS, Peran I, Farag M, Incicco JJ, Bremer A, Grace CR, Soranno A, Pappu RV, and Mittag T. (2020). Valence and patterning of aromatic residues determine the phase behavior of prion-like domains. Science 367, 694&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7297187</ArticleId><ArticleId IdType="pubmed">32029630</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashimo M, Bu X, Aoyama K, Kato J, Ishiwata-Endo H, Stevens LA, Kasamatsu A, Wolfe LA, Toro C, Adams D, et al. (2019). PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells. JCI Insight 4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6478412</ArticleId><ArticleId IdType="pubmed">30830864</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashimo M, Kato J, and Moss J. (2013). ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress. Proc Natl Acad Sci U S A 110, 18964&#x2013;18969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839768</ArticleId><ArticleId IdType="pubmed">24191052</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Gomes E, Guo L, Mojsilovic-Petrovic J, Tran V, Kalb RG, Shorter J, and Bonini NM (2018a). Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. Mol Cell 71, 703&#x2013;717 e709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Mojsilovic-Petrovic J, Van Deerlin VM, Shorter J, Kalb RG, Lee VM, Trojanowski JQ, Lee EB, and Bonini NM (2018b). Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis. Acta Neuropathol Commun 6, 84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6114235</ArticleId><ArticleId IdType="pubmed">30157956</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Rifai OM, and Bonini NM (2019). Poly(ADP-Ribosylation) in Age-Related Neurological Disease. Trends Genet 35, 601&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6625889</ArticleId><ArticleId IdType="pubmed">31182245</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Rifai OM, and Bonini NM (2020). TDP-43, a protein central to amyotrophic lateral sclerosis, is destabilized by tankyrase-1 and &#x2212;2. J Cell Sci 133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7328137</ArticleId><ArticleId IdType="pubmed">32409565</ArticleId></ArticleIdList></Reference><Reference><Citation>Min A, Im SA, Yoon YK, Song SH, Nam HJ, Hur HS, Kim HP, Lee KH, Han SW, Oh DY, et al. (2013). RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib. Mol Cancer Ther 12, 865&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pubmed">23512992</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrea DM, Cika JA, Guy CS, Ban D, Banerjee PR, Stanley CB, Nourse A, Deniz AA, and Kriwacki RW (2016). Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA. Elife 5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4786410</ArticleId><ArticleId IdType="pubmed">26836305</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray DT, Kato M, Lin Y, Thurber KR, Hung I, McKnight SL, and Tycko R. (2017). Structure of FUS Protein Fibrils and Its Relevance to Self-Assembly and Phase Separation of Low-Complexity Domains. Cell 171, 615&#x2013;627 e616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Niaki AG, Sarkar J, Cai X, Rhine K, Vidaurre V, Guy B, Hurst M, Lee JC, Koh HR, Guo L, et al. (2020). Loss of Dynamic RNA Interaction and Aberrant Phase Separation Induced by Two Distinct Types of ALS/FTD-Linked FUS Mutations. Mol Cell.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6943187</ArticleId><ArticleId IdType="pubmed">31630970</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, Stoynov S, Mahamid J, Saha S, Franzmann TM, et al. (2015). A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell 162, 1066&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Portz B, Lee BL, and Shorter J. (2021). FUS and TDP-43 Phases in Health and Disease. Trends Biochem Sci 46, 550&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8195841</ArticleId><ArticleId IdType="pubmed">33446423</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourfarjam Y, Kasson S, Tran L, Ho C, Lim S, and Kim IK (2020). PARG has a robust endo-glycohydrolase activity that releases protein-free poly(ADP-ribose) chains. Biochem Biophys Res Commun 527, 818&#x2013;823.</Citation><ArticleIdList><ArticleId IdType="pubmed">32439163</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S, Wang G, Randle SJ, Ruggeri FS, Varela JA, Lin JQ, Phillips EC, Miyashita A, Williams D, Strohl F, et al. (2018). FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-pi Interactions. Cell 173, 720&#x2013;734 e715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhine K, Makurath MA, Liu J, Skanchy S, Lopez C, Catalan KF, Ma Y, Fare CM, Shorter J, Ha T, et al. (2020a). ALS/FTLD-Linked Mutations in FUS Glycine Residues Cause Accelerated Gelation and Reduced Interactions with Wild-Type FUS. Mol Cell 80, 666&#x2013;681 e668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7688085</ArticleId><ArticleId IdType="pubmed">33159856</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhine K, Skanchy S, and Myong S. (2021). Single-molecule and ensemble methods to probe RNP nucleation and condensate properties. Methods.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8374000</ArticleId><ArticleId IdType="pubmed">33610691</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhine K, Vidaurre V, and Myong S. (2020b). RNA Droplets. Annu Rev Biophys 49, 247&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7695521</ArticleId><ArticleId IdType="pubmed">32040349</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy R, Hohng S, and Ha T. (2008). A practical guide to single-molecule FRET. Nat Methods 5, 507&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3769523</ArticleId><ArticleId IdType="pubmed">18511918</ArticleId></ArticleIdList></Reference><Reference><Citation>Rulten SL, Rotheray A, Green RL, Grundy GJ, Moore DA, Gomez-Herreros F, Hafezparast M, and Caldecott KW (2014). PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage. Nucleic Acids Res 42, 307&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3874156</ArticleId><ArticleId IdType="pubmed">24049082</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar J, and Myong S. (2018). Single-Molecule and Ensemble Methods to Probe Initial Stages of RNP Granule Assembly. Methods Mol Biol 1814, 325&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">29956241</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz JC, Wang X, Podell ER, and Cech TR (2013). RNA seeds higher-order assembly of FUS protein. Cell Rep 5, 918&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3925748</ArticleId><ArticleId IdType="pubmed">24268778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifi R, Morra R, Appel CD, Tallis M, Chioza B, Jankevicius G, Simpson MA, Matic I, Ozkan E, Golia B, et al. (2013). Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease. EMBO J 32, 1225&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3642678</ArticleId><ArticleId IdType="pubmed">23481255</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova TA, Robinson HK, Southcombe JA, Ninkina N, and Buchman VL (2014). Multistep process of FUS aggregation in the cell cytoplasm involves RNA-dependent and RNA-independent mechanisms. Hum Mol Genet 23, 5211&#x2013;5226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159159</ArticleId><ArticleId IdType="pubmed">24842888</ArticleId></ArticleIdList></Reference><Reference><Citation>Singatulina AS, Hamon L, Sukhanova MV, Desforges B, Joshi V, Bouhss A, Lavrik OI, and Pastre D. (2019). PARP-1 Activation Directs FUS to DNA Damage Sites to Form PARG-Reversible Compartments Enriched in Damaged DNA. Cell Rep 27, 1809&#x2013;1821 e1805.</Citation><ArticleIdList><ArticleId IdType="pubmed">31067465</ArticleId></ArticleIdList></Reference><Reference><Citation>Svetoni F, Frisone P, and Paronetto MP (2016). Role of FET proteins in neurodegenerative disorders. RNA Biol 13, 1089&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5100351</ArticleId><ArticleId IdType="pubmed">27415968</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan ES, Krukenberg KA, and Mitchison TJ (2012). Large-scale preparation and characterization of poly(ADP-ribose) and defined length polymers. Anal Biochem 428, 126&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3414684</ArticleId><ArticleId IdType="pubmed">22743307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N, Silani V, LeClerc AL, Keagle P, Gellera C, Ratti A, Taroni F, Kwiatkowski TJ Jr., McKenna-Yasek DM, Sapp PC, et al. (2009). Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology 73, 1180&#x2013;1185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2764725</ArticleId><ArticleId IdType="pubmed">19741215</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Voronkov A, Holsworth DD, Waaler J, Wilson SR, Ekblad B, Perdreau-Dahl H, Dinh H, Drewes G, Hopf C, Morth JP, et al. (2013). Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor. J Med Chem 56, 3012&#x2013;3023.</Citation><ArticleIdList><ArticleId IdType="pubmed">23473363</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Choi JM, Holehouse AS, Lee HO, Zhang X, Jahnel M, Maharana S, Lemaitre R, Pozniakovsky A, Drechsel D, et al. (2018). A Molecular Grammar Governing the Driving Forces for Phase Separation of Prion-like RNA Binding Proteins. Cell 174, 688&#x2013;699 e616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063760</ArticleId><ArticleId IdType="pubmed">29961577</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa T, Ali R, Jiou J, Fung HYJ, Burke KA, Kim SJ, Lin Y, Peeples WB, Saltzberg D, Soniat M, et al. (2018). Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites. Cell 173, 693&#x2013;705 e622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234985</ArticleId><ArticleId IdType="pubmed">29677513</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Wu YC, Mullane P, Ji YJ, Liu H, He L, Arora A, Hwang HY, Alessi AF, Niaki AG, et al. (2018). FUS Regulates Activity of MicroRNA-Mediated Gene Silencing. Mol Cell 69, 787&#x2013;801 e788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5836505</ArticleId><ArticleId IdType="pubmed">29499134</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>